Longtime Sandoz exec announces retirement; Lilly appoints head of India
→ Francisco Ballester is retiring as president, region international at Sandoz on March 1, and Peter Stenico will replace him. Ballester has held this role for six years and was president of Latin...
View ArticleNovo Nordisk takes aim at Roche in hemophilia A, but is way behind
Novo Nordisk said Friday that its hemophilia A preventive Mim8 was effective in its pediatric trial, opening it up to a larger patient population after the treatment succeeded in its pivotal ...
View ArticleBain buys Mitsubishi Tanabe Pharma in $3.3B bet on Japan
The Mitsubishi Chemical Group is selling its centuries-old pharmaceutical business to Bain Capital in a carve-out worth about $3.3 billion. The deal comes after Japan’s Ministry of Health, Labour and...
View ArticleBioluminescence Ventures to shut down 15 months after launch
The life science investment firm Bioluminescence Ventures will close its doors less than two years after its founding, despite raising nearly half a billion dollars to put into new companies, Endpoints...
View ArticleDoctors complete fourth xenotransplant of gene-edited pig kidney
A 66-year-old man whose kidneys were failing is now the fourth person who has received a gene-edited pig kidney, Massachusetts General Hospital announced Friday. Tim Andrews, a resident of Concord, NH ...
View ArticleMajor FDA staff cuts would slow drug reviews, experts say
The Trump administration's reported plans to potentially lay off thousands of FDA employees could slow the agency’s reviews of new drugs, experts say, in addition to impacting other core agency...
View ArticleSanofi, AstraZeneca back Teva's call to rehear case on patent listings
Sanofi, AstraZeneca and two leading trade groups want clarity around an appellate decision that called for Teva to delist five inhaler patents from the FDA’s Orange Book. The drugmakers, along with...
View ArticlePost-Hoc: China tensions both help and hurt Illumina
In the souring US-China relationship, there are winners and losers. DNA sequencing giant Illumina is both. Illumina got bad news this week when China blacklisted it, which could end in restrictions or ...
View ArticleSenators ask FDA to dig into 'misleading' Super Bowl ad from Hims
Sens. Dick Durbin (D-IL) and Roger Marshall (R-KS) are calling on the FDA to take action against a Super Bowl ad coming on Sunday from Hims & Hers that they say "misleads patients" by omitting ...
View Article